Remove category resource-topic business-intelligence
article thumbnail

The Corporate Transparency Act: A Reporting Guide for Medical Groups and MSOs

Healthcare Law Blog

For additional information on a particular topic, links to helpful resources have been provided in the footnotes. Government officials may only access such information for national security, intelligence, and law enforcement purposes. management services agreements, equity restriction or succession agreements).

article thumbnail

Part 2: Who Regulates Healthcare AI?

AIHC

Artificial Intelligence & Regulatory Compliance Written by Joanne Byron , BS, LPN, CCA, CHA, CHCO, CHBS, CHCM, CIFHA, CMDP, COCAS, CORCM, OHCC, ICDCT-CM/PCS This article follows Part 1 - Basics of Artificial Intelligence (AI) and Healthcare Compliance published by AIHC on June 6, 2023. Much has happened since then.

FDA 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hyro Raises $20M in Series B Funding to Advance AI-Powered Communications for Healthcare

Healthcare IT Today

Hyro anticipates that the funding round, coupled with the surge in popularity of OpenAI’s ChatGPT, Google’s Bard, and other large language model (LLM) applications, will catalyze another fiscal year of doubled growth in these categories. Macquarie Capital is thrilled to partner with Hyro on its exciting journey.” Learn more at hyro.ai

article thumbnail

Patient Engagement through Communication Platforms

Healthcare IT Today

Additionally, inter-organizational communication between providers and business associates remains a challenge, with EHR and other IT vendors lacking seamless interoperability between platforms. Advancements in artificial intelligence (AI) can help solve some of these issues. Algorithms can predict wait times for each patient.

Doctors 104
article thumbnail

Day Four Notes for the 40th Annual J.P. Morgan Healthcare Conference, 2022

Healthcare Law Blog

And since the conference was virtual, what better topic to start us off today than a consideration of the new Virtual-First trend that surfaced in 2021. That provider could address the patient’s needs virtually and connect the patient to in-person resources when necessary. Thursday, January 13 was the last day of the virtual J.P.

article thumbnail

Healthcare AI Boom: Avoiding the 3 Big Pitfalls for Success in 2024

HIT Consultant

So, with many companies about to invest significant resources into their AI journey, let’s take a look at some of the pitfalls to avoid. When it comes to compliance, both in the EU and the US, smaller specialized AI models fall into different categories of these regulations.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

The products had been improperly regularized in ANVISA as cosmetics since they are indicated for injectable use, a form that is not authorized for this category of product. The purpose of the note is to clarify that products for invasive aesthetic treatments cannot be regularized in the category of cosmetics.

FDA 52